SG Americas Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.13M | Buy |
|
|||||
|
2025
Q2 | $608K | Sell |
|
|||||
|
2025
Q1 | $19.4M | Buy |
|
|||||
|
2024
Q4 | $145K | Sell |
|
|||||
|
2024
Q3 | $931K | Sell |
|
|||||
|
2024
Q2 | $5.85M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $946K | Sell |
|
|||||
|
2023
Q3 | $2.75M | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $3.04M | Buy |
|
|||||
|
2022
Q4 | $878K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $2.02M | Sell |
|
|||||
|
2022
Q1 | $4.05M | Sell |
|
|||||
|
2021
Q4 | $3.69M | Buy |
|
|||||
|
2021
Q3 | $3.66M | Buy |
|
|||||
|
2021
Q2 | $3.4M | Sell |
|
|||||
|
2021
Q1 | $5.31M | Buy |
|
|||||
|
2020
Q4 | $630K | Sell |
|
|||||
|
2020
Q3 | $1.53M | Buy |
|
|||||
|
2020
Q2 | $1.39M | Sell |
|
|||||
|
2020
Q1 | $1.57M | Buy |
|
|||||
|
2019
Q4 | $145K | Sell |
|
|||||
|
2019
Q3 | $323K | Sell |
|
|||||
|
2019
Q2 | $421K | Buy |
|
|||||
|
2019
Q1 | $186K | Buy |
|
|||||
|
2018
Q4 | $141K | Buy |
|
|||||
|
2018
Q3 | $223K | Sell |
|
|||||
|
2018
Q2 | $2.87M | Buy |
|
|||||
|
2018
Q1 | $111K | Sell |
|
|||||
|
2017
Q4 | $344K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $107K | Sell |
|
|||||
|
2017
Q1 | $1.68M | Sell |
|
|||||
|
2016
Q4 | $2.31M | Buy |
|
|||||
|
2016
Q3 | $164K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $280K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $651K | Buy |
|
|||||
|
2015
Q2 | $198K | Sell |
|
|||||
|
2015
Q1 | $565K | Sell |
|
|||||
|
2014
Q4 | $351K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $151K | Buy |
|
|||||
|
2013
Q2 | $118K | Buy |
|